Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
26.0%
% of FTXH's 51 holdings also in MEDX
43.3%
% of MEDX's 30 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 6.9% | 8.2% | 6.9% |
|
BRISTOL-MYERS SQUIBB CO | 8.7% | 6.1% | 6.1% |
|
JOHNSON & JOHNSON | 6.9% | 4.6% | 4.6% |
|
MERCK & CO. INC. | 6.7% | 4.2% | 4.2% |
|
PFIZER INC | 6.8% | 4.1% | 4.1% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to MEDX
|
GILEAD SCIENCES INC | 4.5% |
|
CARDINAL HEALTH INC | 4.1% |
|
VIATRIS, INC. | 3.8% |
|
ZOETIS INC | 3.8% |
|
UNITED THERAPEUTICS CORP | 3.7% |
 |
JAZZ PHARMACEUTICALS PLC | 3.5% |
|
PFIZER INC | 2.8% |
|
BRISTOL-MYERS SQUIBB CO | 2.6% |
|
ORGANON & CO. | 2.5% |
|
MERCK & CO. INC. | 2.5% |
FTXH Underweight Relative to MEDX
|
ELI LILLY & CO | -13.2% |
 |
NOVARTIS AG-ADR | -5.8% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.1% |
|
ALNYLAM PHARMACEUTICALS INC | -3.7% |
|
ALKERMES PLC | -3.2% |
|
CRISPR THERAPEUTICS AG | -2.9% |
|
AMGEN INC | -2.5% |
|
IONIS PHARMACEUTICALS, INC. | -2.4% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.4% |
|
BEAM THERAPEUTICS, INC. | -1.7% |